THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 105 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is 56.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,000 | -100.0% | 54 | -100.0% | 0.00% | -100.0% |
| Q2 2020 | $6,406,000 | -30.9% | 305,170 | -23.9% | 0.02% | -40.7% |
| Q1 2020 | $9,267,000 | +926600.0% | 400,974 | +10024250.0% | 0.03% | – |
| Q4 2019 | $1,000 | 0.0% | 4 | -81.8% | 0.00% | – |
| Q3 2019 | $1,000 | -99.9% | 22 | -100.0% | 0.00% | -100.0% |
| Q1 2019 | $1,043,000 | -11.4% | 46,008 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $1,177,000 | +14612.5% | 46,008 | +13674.9% | 0.00% | – |
| Q2 2016 | $8,000 | -60.0% | 334 | -67.9% | 0.00% | – |
| Q1 2016 | $20,000 | – | 1,039 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chescapmanager LLC | 1,157,718 | $17,117,000 | 2.77% |
| Baupost Group | 8,735,168 | $129,149,000 | 1.40% |
| Orbimed Advisors | 6,219,110 | $91,950,000 | 1.16% |
| Rubric Capital Management LP | 550,747 | $8,143,000 | 0.76% |
| Cormorant Asset Management, LP | 650,072 | $9,611,000 | 0.37% |
| Rock Springs Capital Management LP | 824,018 | $12,183,000 | 0.31% |
| Virtus ETF Advisers LLC | 23,148 | $342,000 | 0.18% |
| Tekla Capital Management LLC | 298,470 | $4,413,000 | 0.16% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 412,594 | $6,100,000 | 0.16% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $564,000 | 0.10% |